Letter from the SCDM Chair

As I look back at the first 5 months of the year, I am amazed at how much we have accomplished at SCDM! Before I get to our accomplishments, let me share our vision and priorities for the next five years and my focus as the 2025 SCDM Chair. Our 2030 Vision is centered on four key areas: “Clinical Research 2.0”, End-to-End Data Flow, Intelligent Technologies, and Patient’s Choice. In each of these areas, SCDM will identify opportunities in developing an education strategy to advance our profession from Certified Clinical Data Associate (CCDA), through Certified Clinical Data Manager (CCDM), to Certified Clinical Data Scientist (CCDS). Additionally, we want to grow and leverage our partnerships to bring to new ideas, technologies, and processes to SCDM and the industry. Through all of this we grow our global influence.

Institutions

Publication Details

Journal
Journal of the Society for Clinical Data Management
Published
2025-05-15
DOI
https://doi.org/10.47912/jscdm.434
Primary Topic
Intellectual Property Law
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Letter from the SCDM Chair

Journal of the Society for Clinical Data Management
Intellectual Property Law
article

Letter from the SCDM Chair

article en

Abstract

As I look back at the first 5 months of the year, I am amazed at how much we have accomplished at SCDM! Before I get to our accomplishments, let me share our vision and priorities for the next five years and my focus as the 2025 SCDM Chair. Our 2030 Vision is centered on four key areas: “Clinical Research 2.0”, End-to-End Data Flow, Intelligent Technologies, and Patient’s Choice. In each of these areas, SCDM will identify opportunities in developing an education strategy to advance our profession from Certified Clinical Data Associate (CCDA), through Certified Clinical Data Manager (CCDM), to Certified Clinical Data Scientist (CCDS). Additionally, we want to grow and leverage our partnerships to bring to new ideas, technologies, and processes to SCDM and the industry. Through all of this we grow our global influence.

Journal of the Society for Clinical Data ManagementVol. 5(2)
Pfizer (United States) (US)
Openalex Percentile: Top 83%
Intellectual Property Law
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.